Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).

about

Biomarkers in localized prostate cancer.Influence of age on seven putative prostate tumor markers: a cohort study in Chinese men.

P2860

Q38697114-F0CD589D-F029-4A3F-B4F7-BCBEB3BB1277 Q40993267-6D600320-36B6-414F-A7A6-0AEE7E6CA1FB

P2860

Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).

Item

http://www.wikidata.org/entity/Q39023692

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Predictive role of free prosta ...... surveillance program (PRIAS).

@en

Predictive role of free prosta ...... ve active surveillance program

@nl

type

Item

label

Predictive role of free prosta ...... surveillance program (PRIAS).

@en

Predictive role of free prosta ...... ve active surveillance program

@nl

prefLabel

Predictive role of free prosta ...... surveillance program (PRIAS).

@en

Predictive role of free prosta ...... ve active surveillance program

@nl

P1476

Predictive role of free prosta ...... e surveillance program (PRIAS)

@en

P2093

Chris Bangma

http://www.w3.org/2001/XMLSchema#string

Hanna Vasarainen

http://www.w3.org/2001/XMLSchema#string

Heidi Salminen

http://www.w3.org/2001/XMLSchema#string

Jolanda Salman

http://www.w3.org/2001/XMLSchema#string

Tom Pickles

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance

Contemporary trends in low risk prostate cancer: risk assessment and treatment

Active surveillance: towards a new paradigm in the management of early prostate cancer.

ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.

Current applications for prostate-specific antigen doubling time.

MRI and surveillance.

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.

Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.

Assessing individual risk for prostate cancer.

P2888

s00345-015-1542-3

P304

1735-1740

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00345-015-1542-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Valdagni

Antti Rannikko

Monique Roobol

P577

2015-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274262971

http://www.w3.org/2001/XMLSchema#string

P698

25822705

http://www.w3.org/2001/XMLSchema#string

Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).

about

P2860

P2860

Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698